Drugs improving insulin resistance for non‐alcoholic fatty liver disease and/or non‐alcoholic steatohepatitis
There's more to see -- the rest of this topic is available only to subscribers.
Citation
"Drugs Improving Insulin Resistance for Non‐alcoholic Fatty Liver Disease And/or Non‐alcoholic Steatohepatitis." Cochrane Abstracts, John Wiley & Sons, Inc, 2026. Evidence Central, evidence.unboundmedicine.com/evidence/view/Cochrane/437071/all/Drugs_improving_insulin_resistance_for_non‐alcoholic_fatty_liver_disease_and_or_non‐alcoholic_steatohepatitis.
Drugs improving insulin resistance for non‐alcoholic fatty liver disease and/or non‐alcoholic steatohepatitis. Cochrane Abstracts. John Wiley & Sons, Inc; 2026. https://evidence.unboundmedicine.com/evidence/view/Cochrane/437071/all/Drugs_improving_insulin_resistance_for_non‐alcoholic_fatty_liver_disease_and_or_non‐alcoholic_steatohepatitis. Accessed January 13, 2026.
Drugs improving insulin resistance for non‐alcoholic fatty liver disease and/or non‐alcoholic steatohepatitis. (2026). In Cochrane Abstracts. John Wiley & Sons, Inc. https://evidence.unboundmedicine.com/evidence/view/Cochrane/437071/all/Drugs_improving_insulin_resistance_for_non‐alcoholic_fatty_liver_disease_and_or_non‐alcoholic_steatohepatitis
Drugs Improving Insulin Resistance for Non‐alcoholic Fatty Liver Disease And/or Non‐alcoholic Steatohepatitis [Internet]. In: Cochrane Abstracts. John Wiley & Sons, Inc; 2026. [cited 2026 January 13]. Available from: https://evidence.unboundmedicine.com/evidence/view/Cochrane/437071/all/Drugs_improving_insulin_resistance_for_non‐alcoholic_fatty_liver_disease_and_or_non‐alcoholic_steatohepatitis.
* Article titles in AMA citation format should be in sentence-case
TY - ELEC
T1 - Drugs improving insulin resistance for non‐alcoholic fatty liver disease and/or non‐alcoholic steatohepatitis
ID - 437071
BT - Cochrane Abstracts
UR - https://evidence.unboundmedicine.com/evidence/view/Cochrane/437071/all/Drugs_improving_insulin_resistance_for_non‐alcoholic_fatty_liver_disease_and_or_non‐alcoholic_steatohepatitis
PB - John Wiley & Sons, Inc
DB - Evidence Central
DP - Unbound Medicine
ER -

Cochrane Abstracts

